Literature DB >> 11072162

Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity.

K M Alektiar1, J Velasco, M J Zelefsky, J M Woodruff, J J Lewis, M F Brennan.   

Abstract

PURPOSE: Adjuvant radiotherapy (RT) has been shown to improve local control in patients with soft tissue sarcoma of the extremities (STS). The specific impact of adjuvant radiation on patients with positive margins, however, has not been clearly defined. The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection. METHODS AND MATERIALS: Between 8/82 and 2/97, 110 adult patients with primary high-grade STS of an extremity underwent limb sparing surgery and were found to have a histologically positive microscopic surgical margin. Ninety-one (83%) received RT and 19 (17%) had no RT. The two groups were balanced with regard to size, site, location, and tumor depth. Adjuvant RT was delivered with brachytherapy (BRT) alone in 34 patients, external beam radiotherapy (EBRT) alone in 33 patients, or BRT+EBRT in 24 patients. The BRT dose was 45 Gy when used alone and 15-20 Gy when used as a boost. The EBRT dose was 60-70 Gy when used alone and 45-50 Gy when given with BRT. The median follow-up time was 41 months (range, 3-186 months).
RESULTS: The overall 5 year local control rate was 71%. This rate was significantly higher in the RT group compared to the no RT group (74% vs. 56%, respectively) (p = 0.01). On univariate analysis, lower extremity site and proximal location were also found to be predictors of improved local control (p = 0.03 and 0.03, respectively). However, only proximal location and the use of RT retained their significance as predictors of improved local control on multivariate analysis (p = 0.003 and 0.01, respectively). The overall 5-year distant relapse-free survival, disease-free survival, and overall survival rates were 54%, 44%, and 53%, respectively. No statistical differences were found in these survival rates between RT and no RT groups.
CONCLUSION: Based on this study, adjuvant radiotherapy seems to improve local control in patients with high-grade STS of the extremity with positive margins. However, local recurrence still occurs in a substantial proportion of patients, mandating further need for improvement.

Entities:  

Mesh:

Year:  2000        PMID: 11072162     DOI: 10.1016/s0360-3016(00)00753-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  34 in total

1.  Soft tissue sarcoma clinical practice guidelines in oncology.

Authors:  George D Demetri; Laurence H Baker; Derrick Beech; Robert Benjamin; Ephraim S Casper; Ernest U Conrad; Thomas F DeLaney; David S Ettinger; Martin J Heslin; Ray J Hutchinson; Krystyna Kiel; William G Kraybill; G Douglas Letson; James Neff; Richard J O'Donnell; I Benjamin Paz; Raphael E Pollock; R Lor Randall; Karen D Schupak; Douglas S Tyler; Margaret von Mehren; Jeffrey Wayne
Journal:  J Natl Compr Canc Netw       Date:  2005-03       Impact factor: 11.908

2.  Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.

Authors:  Emily Z Keung; Jen-Wei Tsai; Ali M Ali; Janice N Cormier; Andrew J Bishop; B Ashleigh Guadagnolo; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Jennifer A Wargo; Alexander J Lazar; Wei-Lien Wang; Christina L Roland
Journal:  Oncoimmunology       Date:  2017-10-31       Impact factor: 8.110

3.  Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.

Authors:  Kyle C Cuneo; Richard F Riedel; Leslie G Dodd; David H Harpole; David G Kirsch
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

Review 4.  Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Authors:  Makoto Endo; Nokitaka Setsu; Toshifumi Fujiwara; Takeaki Ishii; Makoto Nakagawa; Kenichiro Yahiro; Atsushi Kimura; Eijiro Shimada; Yasuharu Nakashima; Yoshihiro Matsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 5.  [Late complications following neo-/adjuvant radiotherapy and surgery for sarcomas of the extremities or pelvis/retroperitoneum : Preventative measures].

Authors:  C Jentsch; C Hofbauer; S Makocki; E Troost
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

6.  Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity.

Authors:  Michael R Folkert; Samuel Singer; Murray F Brennan; Deborah Kuk; Li-Xuan Qin; Wendy K Kobayashi; Aimee M Crago; Kaled M Alektiar
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

7.  Guidelines for the management of soft tissue sarcomas.

Authors:  Robert Grimer; Ian Judson; David Peake; Beatrice Seddon
Journal:  Sarcoma       Date:  2010-05-31

8.  Soft tissue sarcomas of the hand: functional reconstruction and outcome analysis.

Authors:  Brian I Labow; Heather Rosen; Arin K Greene; W P Andrew Lee; Joseph Upton
Journal:  Hand (N Y)       Date:  2008-07-03

9.  Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract.

Authors:  Odion Binitie; Shawn Tejiram; Sheila Conway; David Cheong; H Thomas Temple; G Douglas Letson
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

10.  Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma.

Authors:  Arash O Naghavi; Ricardo J Gonzalez; Jacob G Scott; John E Mullinax; Yazan A Abuodeh; Youngchul Kim; Odion Binitie; Kamran A Ahmed; Marilyn M Bui; Amarjit S Saini; Jonathan S Zager; Matthew C Biagioli; Douglas Letson; Louis B Harrison; Daniel C Fernandez
Journal:  Brachytherapy       Date:  2016-05-12       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.